Reviva Pharmaceuticals Holdings Inc.

08/21/2024 | Press release | Distributed by Public on 08/21/2024 04:08

Reviva Pharmaceuticals Announces Pricing of $5.0 Million Underwritten Offering Priced At the Market Under Nasdaq Rules Earnings Release